by lrevers | Oct 10, 2021 | Publications
D5Pharma’s most recent publication on PEG:CCS13. Functional aptamers displaying agonistic or antagonistic properties are showing great promise as modulators of immune responses. Here, we report the development of a polyethylene glycol-modified (PEGylated) DNA...